Transposable elements are a prominent feature of our genetic heritage. In addition to providing nearly half of the human genome,[@R1]^,^[@R2] TEs have generated numerous sequences that distinguish our DNA from that of other primates and more distant relatives.[@R3]^,^[@R4] Whether these differences are a cause or effect of evolution, and whether TEs are parasitic or symbiotic mobile genetic elements, is the subject of long-term debate.[@R5]^,^[@R6]

Three retrotransposon families remain mobile in the human genome: L1, *Alu* and SVA.[@R7]^,^[@R8] Of these, L1 is considered the main driver of retrotransposition ([Fig. 1A](#F1){ref-type="fig"}). Proteins translated from its two open reading frames mobilize L1 RNAs in cis[@R9] as well as *Alu*, SVA and other RNAs incorporating a polyA tail in trans[@R10]^-^[@R12] ([Fig. 1D](#F1){ref-type="fig"}). Approximately 3,000 retrotransposons (\~100 L1, \~3,000 *Alu*, \< 100 SVA) are transposition-competent per individual,[@R13] in contrast to the millions of immobile sequences produced by ancestral TEs.[@R1]

![**Figure 1.** L1 is the main driver of retrotransposition in human cells. (A) L1 structure. ORF1 encodes an RNA-packaging protein and ORF2 encodes a protein (ORF2p) with endonuclease and reverse transcriptase domains.[@R50]^,^[@R51] (B) Expression of L1 is limited by transcriptional repression and (C) post transcriptional regulation. (D) L1 ORF1p and ORF2p form an RNP with a marked cis preference,[@R9] but ORF2p can also mobilize other RNAs with a polyA tail in trans. (E) Diverse effects of L1 insertional mutagenesis on gene expression. (F) L1 is known to be highly active during embryogenesis, and in neural cells (G), resulting in somatic mosaicism. Somatic retrotransposition in other adult tissues may also occur.](mge-1-279-g1){#F1}

Other than a common pattern of near-exclusion from exons,[@R14] the genomic distributions of L1, *Alu* and SVA are markedly different. L1 sequences are depleted in introns[@R1] and very recent L1 insertions are more likely to be excluded from protein-coding genes than older insertions,[@R14]^,^[@R15] suggesting that these events are strongly selected against.[@R16]^,^[@R17] By contrast, recent *Alu* insertions are almost randomly distributed in the genome and SVA insertions are enriched in protein-coding genes.[@R14] As noted above, the L1 machinery mediates L1, *Alu* and SVA mobilization, implying that each family is inserted in a similar genomic pattern and then redacted from the genome by natural selection depending on their impact. It is also possible that insertion site preference is modulated by unknown host factor interactions specific to each family.

An obvious consequence of insertional mutagenesis is genetic disease; TEs are associated with more than 75 human disorders.[@R13]^,^[@R18] Likewise there are numerous documented cases of alternative transcripts and chimeric genes produced by TE insertions, often leading to expression of a host gene in a new spatiotemporal context[@R19]^,^[@R20] ([Fig. 1E](#F1){ref-type="fig"}). Several L1 sequence features, including a long polyA tail and strong internal 5′ and 3′ promoters[@R19]^,^[@R21] can also dramatically alter the expression of a host gene in cases of intronic integration,[@R17] while the epigenetic marks associated with L1 and other retrotransposons[@R22] can modify chromatin state at integration sites and thereby drive rapid shifts in gene expression ([Fig. 1E](#F1){ref-type="fig"}).

Given the multiple routes by which TEs can deleteriously alter the functional landscape of a genome, it is perhaps surprising that the global human population presents such a large number of dimorphic insertions.[@R23] Recent studies using high-throughput sequencing (for reviews, see refs. [@R13], [@R24] and [@R25]) have yielded a wealth of new insertion sites in healthy and diseased individuals, suggesting the full catalog of dimorphic and private insertions has been vastly underestimated and that roughly 1/20 live births harbor de novo retrotransposition events.

Most of these new insertions are thought to be neutral and are ultimately lost or fixed through genetic drift. The overall impact of the remaining insertions is likely to be overwhelmingly deleterious, raising the question of why retrotransposition is allowed to continue at an apparently high rate. More effective TE suppression would prevent harmful mutations, both in the germline and during somatic development.[@R26] A model of successful parasitism would suggest that we have simply failed; that somehow despite a clear selective advantage to the host in silencing retrotransposons, L1 has managed to evade all attempts to prevent its activity. However, suppression of L1 *has* been effective during our recent evolution: less than 0.002% of human L1 copies are transposition-competent, and even fewer are frequently active or "hot"[@R7]^,^[@R27]. While the current state of L1 activity is a snapshot of a dynamic system, this could nonetheless suggest that it is evolutionarily advantageous to limit retrotransposition but not to totally eradicate it. For example, the South American rat genus Oryzomys[@R28]^,^[@R29] has won this evolutionary arms race, apparently achieving L1 quiescence but, interestingly, this outcome coincides with a notable increase in karyotypic instability.[@R30]

This leads us to consider the position that regulated germline retrotransposition confers a benefit upon a host population. L1 provides clues for how this system may have co-evolved with the governing transcriptional programs of the host. Paradoxically, the canonical L1 promoter has retained motifs necessary for its transcriptional suppression in the germline and throughout development (e.g., SOX2 binding sites[@R31]^,^[@R32]) while new, usually 5′ truncated, L1 insertions are rapidly inactivated despite breaking free of the suppression inherent to the canonical L1 promoter[@R33]^,^[@R34] ([Fig. 1B and C](#F1){ref-type="fig"}). Thus, L1 maintains its own suppression but is not entirely silenced, leading to a tolerable rate of insertional mutagenesis while maintaining increased genomic malleability and genetic diversity that may be selected on when a population is strongly pressured (e.g., in the cases of pandemic or famine). For example, an L1-mediated TRIM5-CypA gene fusion[@R35] following the divergence of Old and New World primates provides owl monkeys with HIV resistance not seen in other New World monkeys.

Nonetheless, a model founded exclusively upon observations of germline retrotransposition may be critically incomplete. We propose that L1 activity during ontogenesis[@R36]^-^[@R38] ([Fig. 1F and G](#F1){ref-type="fig"}) may serve to accelerate TE and host co-evolution. Recent reports suggest that the brain is a hotspot of somatic mosaicism caused by L1 mobilization during neurogenesis.[@R31]^,^[@R39]^-^[@R41] If calculations of 80 somatic L1 insertions per neuron, of which there are \~10^11^ present in the human body,[@R42] are even approximately accurate,[@R31] then a single human individual may have more somatic L1 insertions than the *total* number of private germline L1 insertions in the global population. Informing this scenario further, we recently developed a technology to map somatic L1 insertions in human cells.[@R39] Our principal conclusions were that these events preferentially impacted protein-coding genes expressed in the brain, that the hippocampus---as seen previously[@R31]---was particularly enriched for somatic retrotransposition and that neural cells indeed present[@R43] a remarkable degree of somatic genome mosaicism. Despite this advance, numerous questions are yet to be answered, including (1) the timing of somatic L1 mobilization throughout life; (2) how many events occur per individual, organ or cell; (3) whether certain population groups are particularly affected; (4) which transcription factors govern L1 activation in somatic cells other than neurons and (5) whether the same rules that apply in germ cells (e.g., a limited number of "hot" donor elements and families[@R7]^,^[@R27]) also apply to somatic cells.

Moreover, as somatic events are by definition non-heritable, it is the propensity for L1 mobilization, rather than its consequences, on which natural selection may apply. If true, this may suggest that the brain is enriched for somatic mobilization as an innocent bystander in an evolutionary arms race occurring primarily in the germline. A large percentage of genes expressed in the brain are also expressed in the testis (the "brains and balls" phenomenon[@R44]), meaning that L1 transcription may be activated in somatic cells as an accident of evolution. The mutagenic effects of these insertions may then be simply tolerated by somatic cells; in addition to a reduction in impact due to heterozygosity, each mutation is expected to affect only a small sub-population of mature cells.

Another, more striking, possibility is that somatic retrotransposition confers some primary gain upon the individual host. As noted by others,[@R45] Barbara McClintock's celebrated discovery of transposition-derived kernel variegation in maize[@R46] was also the first description of somatic mosaicism caused by a transposable element. Singer et al.[@R43] more recently provided a compelling case for the potential action of L1 in producing somatic mosaicism in neural cells, resulting in greater genetic diversity and thus a greater variety of behavioral phenotypes in isogenic animals. As at the population level, genetic diversity may be beneficial at the cellular level. One classic example, driven by RAG proteins domesticated from an ancient transposon,[@R47]^,^[@R48] is V(D)J recombination, where somatic rearrangements in immunoglobins and T-cell receptors[@R49] provide genetic diversification crucial for the adaptive immune system.

The contribution of TEs to the fitness and success of species may not be limited to their well-documented effects on the genome mediated through germline retrotransposition. Their potential role in driving genetic diversity both within and between individuals adds yet another layer to the complex relationship between TEs and their hosts. Characterization of the regulation and functional impact of somatic retrotransposition is now feasible,[@R39] and may soon settle debate on whether TEs are merely globally successful parasites, or diverse genomic symbiotes.
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